within Pharmacolibrary.Drugs.D_Dermatologicals.D07X_CorticosteroidsOtherCombinations.D07XC05_Fluocortolone;

model Fluocortolone
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.3,
    Cl = 4.166666666666667e-06,
    adminDuration = 600,
    adminMass = 20 / 1000000,
    adminCount = 1,
    Vd = 0.06,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0008333333333333334,
    Tlag = 600);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Fluocortolone</td></tr><tr><td>ATC code:</td><td>D07XC05</td></tr><td>route:</td><td>rectal</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>20</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>60</td><td>L</td></tr>
    <tr><td>clearance:</td><td>15</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Fluocortolone is a synthetic corticosteroid with anti-inflammatory and immunosuppressive properties. It has been primarily used topically in dermatology for the treatment of skin disorders such as eczema and dermatitis, and rectally (as suppositories or ointments) for hemorrhoids and proctitis. Its use is approved in select countries, mainly in Europe.</p><h4>Pharmacokinetics</h4><p>No specific pharmacokinetic parameters for fluocortolone in humans were found in referenced publications. Pharmacokinetic parameters estimated based on class properties (corticosteroids), route, and typical doses for topical or rectal use.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.D.D07XC05 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Fluocortolone;
